1. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway
    Chuanxi Yang et al, 2020, European Journal of Pharmacology CrossRef
  2. Inhibitory Effects of Roseoside and Icariside E4 Isolated from a Natural Product Mixture (No-ap) on the Expression of Angiotensin II Receptor 1 and Oxidative Stress in Angiotensin II-Stimulated H9C2 Cells
    Eun Hong et al, 2019, Molecules CrossRef
  3. Regulation of TGF‑β1 on PI3KC3 and its role in hypertension‑induced vascular injuries
    Qin Zhang et al, 2018, Experimental and Therapeutic Medicine CrossRef
  4. Investigation of the effects of tadalafil and telmisartan in bleomycin-induced pulmonary fibrosis on rats
    İ̇lke Onur KAZAZ et al, 2020, Journal of Surgery and Medicine CrossRef
  5. Study on the Potential Mechanism of Fructus Tribuli in the Treatment of Hypertensive Vascular Remodeling Based on Network Pharmacology and Molecular Docking
    Shuyue Wang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  6. Zinc complexation improves angiotensin II receptor type 1 blockade and in vivo antihypertensive activity of telmisartan
    Valeria R Martínez et al, 2021, Future Medicinal Chemistry CrossRef
  7. The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases
    Andrés García-Sánchez et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  8. Aloe-Emodin Ameliorates Renal Fibrosis Via Inhibiting PI3K/Akt/mTOR Signaling Pathway In Vivo and In Vitro
    Fang Dou et al, 2019, Rejuvenation Research CrossRef
  9. An insight into the role of telmisartan as PPAR‐γ/α dual activator in the management of nonalcoholic fatty liver disease
    Aswathy R. Devan et al, 2022, Biotechnology and Applied Biochemistry CrossRef
  10. miR-126a-3p targets HIF-1α and alleviates obstructive sleep apnea syndrome with hypertension
    Lirong He et al, 2020, Human Cell CrossRef
  11. The antagonistic effects and mechanisms of microRNA‐26a action in hypertensive vascular remodelling
    Wenqian Zhang et al, 2021, British Journal of Pharmacology CrossRef